Skip to Main Content

Paper Details

Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.
Sci Transl Med
5
2023
1273, Delta, K18, N, NTD, SARS-CoV, SARS-CoV-2, coronavirus disease, full-, hACE2, mRNA, mRNA-1273, mRNA-1283, messenger RNA, mice, spike protein, wild-type spike protein receptor binding domain
Author NameAffiliation
Guillaume B E Stewart-JonesInc.
Larissa B ThackrayWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
  • 1 - 5

Datasets

Release 1.2